The National Institutes of Health's Big Data to Knowledge (BD2K) initiative: capitalizing on biomedical big data

Abstract

Biomedical research has and will continue to generate large amounts of data (termed ‘big data’) in many formats and at all levels. Consequently, there is an increasing need to better understand and mine the data to further knowledge and foster new discovery. The National Institutes of Health (NIH) has initiated a Big Data to Knowledge (BD2K) initiative to maximize the use of biomedical big data. BD2K seeks to better define how to extract value from the data, both for the individual investigator and the overall research community, create the analytic tools needed to enhance utility of the data, provide the next generation of trained personnel, and develop data science concepts and tools that can be made available to all stakeholders.

Prevalence of hypercalcemia among cancer patients in the United States

“…Recently, there has been great interest in real‐world data, electronic health data, and the promise of “big data” 20, and how to translate them into new knowledge 21. The adoption of EHR is particularly relevant in oncology, relative to other medical specialties, where adoption of EHR has become part of the clinical care of patients 22.…”

Big Data in Bioinformatics

“…Правительство США выделило 200 млн. долларов на финансирование программ Big Data и NIH Big Data to Knowledge (BD2K) initiative [65]. Программа Big Data в частности, направлена на значительное усовершенствование инструментов и методов доступа, организации и сбора данных об открытиях, связанных с огромными объемами цифровых данных.…”

The Big Data Era in Healthcare: Promises and Challenges

“…Data analysis is creating great opportunities for doctors, epidemiologists and the policy makers in health care sector. [14] shows that Big data is not only a reality for biomedicine experts, but also an effective tool for the perception and search of new knowledge. Access to the data generated by Omics technologies has led to revolutionary changes in the field of medical biology, bioinformatics and other fields of science.…”